Steward Partners Investment Advisory’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9K | Sell |
734
-43,021
| -98% | -$934K | ﹤0.01% | 3008 |
|
|
2025
Q1 | $1.06M | Buy |
43,755
+42,482
| +3,337% | +$1.03M | 0.01% | 895 |
|
|
2024
Q4 | $26.6K | Buy |
+1,273
| New | +$26.6K | ﹤0.01% | 2644 |
|
|
2024
Q1 | – | Sell |
-600
| Closed | -$10.1K | – | 3592 |
|
|
2023
Q4 | $10.1K | Hold |
600
| – | – | ﹤0.01% | 2709 |
|
|
2023
Q3 | $7.01K | Buy |
600
+100
| +20% | +$1.17K | ﹤0.01% | 2705 |
|
|
2023
Q2 | $6.72K | Buy |
500
+300
| +150% | +$4.03K | ﹤0.01% | 2695 |
|
|
2023
Q1 | $3.32K | Buy |
200
+120
| +150% | +$1.99K | ﹤0.01% | 2911 |
|
|
2022
Q4 | $1.49K | Hold |
80
| – | – | ﹤0.01% | 3077 |
|
|
2022
Q3 | $1K | Buy |
+80
| New | +$1K | ﹤0.01% | 3109 |
|
|
2021
Q2 | – | Sell |
-2,600
| Closed | -$12K | – | 7142 |
|
|
2021
Q1 | $12K | Buy |
+2,600
| New | +$12K | ﹤0.01% | 2704 |
|
|
2020
Q1 | – | Sell |
-2,500
| Closed | -$9K | – | 2521 |
|
|
2019
Q4 | $9K | Sell |
2,500
-2,000
| -44% | -$7.2K | ﹤0.01% | 2042 |
|
|
2019
Q3 | $23K | Buy |
4,500
+2,000
| +80% | +$10.2K | ﹤0.01% | 1675 |
|
|
2019
Q2 | $9K | Buy |
+2,500
| New | +$9K | ﹤0.01% | 2012 |
|
|
2018
Q4 | – | Sell |
-2,500
| Closed | -$9K | – | 1020 |
|
|
2018
Q3 | $9K | Hold |
2,500
| – | – | ﹤0.01% | 1910 |
|
|
2018
Q2 | $8K | Buy |
+2,500
| New | +$8K | ﹤0.01% | 1807 |
|